Log in

LON:CRX - Cyprotex Share Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume22,515 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cyprotex PLC is a holding company. The Company and its subsidiaries are engaged in the provision of in vitro and in silico Absorption, Distribution, Metabolism, Excretion, Toxicity (ADMET) and Pharmacokinetic (PK) information to the pharmaceutical and biotechnology industries. It offers a range of different services in the areas of ADME-PK, in vitro toxicology, biosciences, in silico prediction, in vitro skin and ocular testing, endocrine disruption and physicochemical profiling. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+44-1625-505100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CRX News and Ratings via Email

Sign-up to receive the latest news and ratings for CRX and its competitors with MarketBeat's FREE daily newsletter.


Cyprotex (LON:CRX) Frequently Asked Questions

What is Cyprotex's stock symbol?

Cyprotex trades on the London Stock Exchange (LON) under the ticker symbol "CRX."

Has Cyprotex been receiving favorable news coverage?

News stories about CRX stock have trended somewhat positive recently, according to InfoTrie. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cyprotex earned a news impact score of 1.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Cyprotex.

What other stocks do shareholders of Cyprotex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyprotex investors own include Organovo (ONVO), CGG (CGG), Energy Transfer LP Unit (ET), Norwegian Cruise Line (NCLH), Cisco Systems (CSCO), Torotrak (TRK), Monitise (MONI), KAZ Minerals (KAZ), International Consolidated Airlns Grp (IAG) and eServGlobal (ESG).

How do I buy shares of Cyprotex?

Shares of CRX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Cyprotex's official website?

The official website for Cyprotex is http://www.cyprotex.com/.

How can I contact Cyprotex?

Cyprotex's mailing address is 24, Mereside, Alderley Park, MACCLESFIELD, SK10 4TG, United Kingdom. The company can be reached via phone at +44-1625-505100.


MarketBeat Community Rating for Cyprotex (LON CRX)

Community Ranking:  1.2 out of 5 (star)
Outperform Votes:  52 (Vote Outperform)
Underperform Votes:  158 (Vote Underperform)
Total Votes:  210
MarketBeat's community ratings are surveys of what our community members think about Cyprotex and other stocks. Vote "Outperform" if you believe CRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel